Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidog (Q42962304)
Jump to navigation
Jump to search
scientific article published on July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidog |
scientific article published on July 2010 |
Statements
1 reference
Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidog (English)
1 reference
1 reference
Young-Hoon Jeong
1 reference
In-Suk Kim
1 reference
Yongwhi Park
1 reference
Min-Kyung Kang
1 reference
Jin-Sin Koh
1 reference
Seok-Jae Hwang
1 reference
Jin-Yong Hwang
1 reference
1 July 2010
1 reference
1 reference
3
1 reference
7
1 reference
731-741
1 reference
Identifiers
1 reference
1 reference